Home

Cavu Advisors, Director: Actuate Therapeutics ACTU Buy · Filed 25/06/30

Trade details

Type
Insider buy
Amount
$499,996
Shares · price
71,428 sh · $7.00 a share
Held after
196,428 sh
Trade date
25/06/27
Filed
25/06/30
Days to filing
3 days

First buy since 2023

Insiders buying this week
24 insiders
Holding change
+57.1%

Actuate Therapeutics trades, last 26 weeks

What else happened in Actuate Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/28~25/07/27

Cavu Advisors's recent trades

  • Cavu Advisors

    SellLantern Pharma

    $43.9K

    Filed 25/06/13

  • Cavu Advisors

    SellLantern Pharma

    $38.1K

    Filed 25/06/13

  • Cavu Advisors

    SellLantern Pharma

    $22.3K

    Filed 25/06/13

  • Cavu Advisors

    SellLantern Pharma

    $13.5K

    Filed 25/06/13

  • Cavu Advisors

    SellLantern Pharma

    $5,880

    Filed 25/06/13

Cavu Advisors, Director — bought $500K of Actuate Therapeutics ACTU · 71,428 sh @ $7.00 | Whalegun